Omega3-fatty acid (Omacor) therapy for atrial fibrillation prevention after surgical myocardial revascularization (AXIOMA Study)
https://doi.org/10.18705/1607-419X-2008-14-2-162-164
Abstract
Resume
The article contains results of using щ-3 polyunsaturated fatty acids in atrial fibrillation prevention after myocardial revascularization.
Increased coronary artery bypass graft surgery (CABG) rates in Russia require active implementation of methods improving short and long-term outcome. Secondary coronary artery disease prevention includes risk factors control, antiaggregant, beta-adrenoblocker, lipid-lowring and ACE inhibitor therapy. Recent studies have showed beneficial щ-3 polyunsaturated fatty acids role in improving CABG outcomes.
The article contains results of using щ-3 polyunsaturated fatty acids in atrial fibrillation prevention after myocardial revascularization.
Increased coronary artery bypass graft surgery (CABG) rates in Russia require active implementation of methods improving short and long-term outcome. Secondary coronary artery disease prevention includes risk factors control, antiaggregant, beta-adrenoblocker, lipid-lowring and ACE inhibitor therapy. Recent studies have showed beneficial щ-3 polyunsaturated fatty acids role in improving CABG outcomes.
About the Authors
A. V. Panov
Федеральный центр сердца, крови и эндокринологии имени В.А. Алмазова
Russian Federation
Russian Federation
M. Gordeev
Федеральный центр сердца, крови и эндокринологии имени В.А. Алмазова
Russian Federation
Russian Federation
R. Y. Nilk
Федеральный центр сердца, крови и эндокринологии имени В.А. Алмазова
Russian Federation
Russian Federation
K. Korzhenevskaya
Федеральный центр сердца, крови и эндокринологии имени В.А. Алмазова
Russian Federation
Russian Federation
E. Usova
Федеральный центр сердца, крови и эндокринологии имени В.А. Алмазова
Russian Federation
Russian Federation
References
1. Bang H., Dyerberg J. et al. The composition of the Eskimo food in Northwestern Greenland. Am J Clin Nutr. 1980; 33: 2657-66.
2.
3. Calo L., Bianconi L., Collivicchi F. et al. Prevention of atrial fibrillation by n-3 polyunsaturated fatty acids after coronarv artery bypass grafting. J Am Coll Cardiol. 2005; 45:1723-8.
4.
5. Eagle and Guyton et al. ACC/AHA 2004 GuidelineUpdate for Coronary Artery Bypass Graft Surgery. AHA www.americanheart.org <http://americanheart.org>.
6.
7. Harris W., Reid K., Sands S., Spertus J. Red blood cell omega-3 fatty acids in acute coronary syndrome patients. Circulation 2007; Vol.115(8): P267.
8.
9. John A. Belperio, Michael P. et al. CXC chemokines in angiogenesis Journal of Leukocyte Biology 2000;68:123-6
10.
11. Marchioli R. et al. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the GlSSI-Prevenzione. Circulation 2002; 105:1897-1903.
12.
13. Ommen S., Odell J., Stanton M. Atrial arrhytmias after cardiothoracic surgery. N Engl J Med 1997; 336: 1429-34
14.
15. Yokoyama M. et al. Fish oil bolsters statin reduction of coronary events 2007; 369: 1090-1098.
16.
Review
For citations:
Panov A.V., Gordeev M., Nilk R.Y., Korzhenevskaya K., Usova E. Omega3-fatty acid (Omacor) therapy for atrial fibrillation prevention after surgical myocardial revascularization (AXIOMA Study) . "Arterial’naya Gipertenziya" ("Arterial Hypertension"). 2008;14(2):162-164. (In Russ.) https://doi.org/10.18705/1607-419X-2008-14-2-162-164
Views:
924
Email this article 